E-mail this story

Roche won't extend $6.8 billion bid for San Diego's Illumina

Swiss drugmaker Roche will not extend its hostile $6.8-billion bid for Illumina Inc. after the San Diego biotech company’s shareholders rejected Roche’s attempts to appoint new board members.

By Tiffany Hsu

April 18, 2012

Send to (as many as 3 e-mail addresses, separated by commas):

Send me a copy.

From:

200 characters remaining